Mercer Global Advisors Inc Bridge Bio Pharma, Inc. Transaction History
Mercer Global Advisors Inc
- $39.5 Billion
- Q2 2024
A detailed history of Mercer Global Advisors Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 14,198 shares of BBIO stock, worth $367,444. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,198
Previous 14,271
0.51%
Holding current value
$367,444
Previous $441,000
18.59%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BBIO
# of Institutions
294Shares Held
177MCall Options Held
8.72MPut Options Held
2.75M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$804 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$650 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$364 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$322 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$157 Million67.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.84B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...